Drugs and investigations planned on discharge after AMI
| Treatment | OR for treatment of women (95% confidence intervals) | Age adjusted OR for treatment of women (95% confidence intervals) |
|---|---|---|
| Aspirin | 0.64 (0.48, 0.85, p=0.00) | 0.91 (0.68, 1.23, p=0.55) |
| β blockers | 0.54 (0.44, 0.66, p=0.00) | 0.84 (0.67, 1.07, p=0.15) |
| ACE inhibitors | 1.09 (0.88, 1.34, p=0.44) | 1.01 (0.81, 1.26, p=0.91) |
| Antiarrythmics | 1.22 (0.89, 1.68, p=0.22) | 0.84 (0.60, 1.18, p=0.32) |
| Anticoagulants | 1.22 (0.85, 1.73, p=0.28) | 1.40 (0.97, 2.03, p=0.07) |
| Calcium antagonists | 1.28 (1.00, 1.65, p=0.05) | 1.25 (0.96, 1.63, p=0.09) |
| Nitrates | 0.95 (0.78, 1.17, p=0.63) | 0.85 (0.69, 1.06, p=0.15) |
| Statins | 0.88 (0.60, 1.27, p=0.48) | 1.37 (0.92, 2.03, p=0.12) |
| Angiography | 0.29 (0.14, 0.62, p=0.00) | 0.48 (0.22, 1.02, p=0.06) |
| Exercise testing | 0.43 (0.33, 0.55, p=0.00) | 0.69 (0.53, 0.92, p=0.01) |
| CABG/PTCA | 0.35 (0.12, 1.04, p=0.06) | 0.58 (0.19, 1.73, p=0.33) |